Suzuken Co., Ltd. (TYO:9987)
Japan
· Delayed Price · Currency is JPY 5,872.00
-99.00 (-1.66%)
At close: Dec 5, 2025
Suzuken Revenue
Suzuken had revenue of 626.57B JPY in the quarter ending September 30, 2025, with 1.86% growth. This brings the company's revenue in the last twelve months to 2.42T, up 1.37% year-over-year. In the fiscal year ending March 31, 2025, Suzuken had annual revenue of 2.40T with 0.56% growth.
Revenue (ttm)
2,422.07B
Revenue Growth
+1.37%
P/S Ratio
0.17
Revenue / Employee
187.42M
Employees
12,923
Market Cap
404.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2,399.95B | 13.46B | 0.56% |
| Mar 31, 2024 | 2,386.49B | 71.67B | 3.10% |
| Mar 31, 2023 | 2,314.83B | 82.05B | 3.67% |
| Mar 31, 2022 | 2,232.77B | 104.56B | 4.91% |
| Mar 31, 2021 | 2,128.22B | -85.26B | -3.85% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |
Suzuken News
- 18 days ago - Suzuken Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation - Seeking Alpha